(GDF8) Latency, Activation, and Antagonism

Total Page:16

File Type:pdf, Size:1020Kb

(GDF8) Latency, Activation, and Antagonism Molecular mechanisms of growth differentiation factor 8 (GDF8) latency, activation, and antagonism A dissertation submitted to the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy In the Department of Molecular Genetics, Biochemistry, and Microbiology of the College of medicine by Jason C. McCoy B.S. Miami University August 2020 Committee Chair: Thomas Thompson, Ph.D. i Abstract Growth differentiation factor 8 (GDF8), a.k.a. myostatin, is a member of the activin subclass within the larger TGFβ superfamily of signaling ligands that contains over 30 distinct members. Discovered in 1997, GDF8 quickly became characterized as a negative regulator of muscle mass because a highly active GDF8 caused muscle wasting or atrophy. In contrast, when GDF8 is rendered inactive through extracellular inhibitors or mutations, massive muscle gain was observed. This discovery generated massive interest within the pharmaceutical industry to manufacture inhibitors for GDF8 to combat a variety of muscle wasting diseases. A better understanding of how GDF8 is regulated in vivo is imperative to develop efficacious and novel inhibitors against GDF8. The activity of GDF8 is tightly regulated in vivo by several different processes. TGFβ ligands are synthesized as large precursor proteins with a N-terminal signal sequence and prodomain followed by the mature signaling domain. The prodomain is cleaved from the mature domain, but unlike most other TGFβ family members, GDF8 forms a high affinity interaction with its prodomain rendering it inactive or latent. Prior to our work, the molecular mechanisms dictating latency were not well understood but were hypothesized to be like the latent TGFβ1 procomplex. Using the TGFβ1 procomplex as a model, we identified residues critical for a stable latent GDF8 procomplex. Furthermore, the structure of the latent GDF8 procomplex was solved by another laboratory and our mutants could be further characterized to determine the molecular mechanisms of GDF8 latency. In order to signal, latent GDF8 needs to be activated by a member of the tolloid family of metalloproteases which proteolytically cleaves the prodomain. While the site of tolloid cleavage on the GDF8 prodomain has been identified, how tolloid recognized the prodomain as a substrate was unknown. Unlike other proteases, tolloid has no concrete consensus sequence required for cleavage. We sought to characterize what molecular features of the GDF8 cut site were required for tolloid processing. To this end, we identified several residues near the cut site that when mutated significantly reduced latent GDF8 activation by tolloid. Although GDF8 is tightly regulated through the formation of a latent procomplex, there are also ii extracellular antagonists that will bind to GDF8 and prevent it from signaling. Of the antagonists that target GDF8, the WFIKKN family is by far the most specific. However, the driver of this specificity was not well defined. Here, we characterized the follistatin domain (FSD) of WFIKKN2. Previously, the FSD had been identified as a primary driver of the high affinity interaction between GDF8 and WFIKKN. We solved the crystal structure of the WFIKKN2 FSD and identified key residues for antagonism and characterized how the FSD of WFIKKN contributes to antagonism. Together, our in vitro data provide valuable insight into the molecular mechanisms dictating GDF8 regulation in vivo and has the potential to be leveraged by the pharmaceutical industry to develop novel approaches for GDF8 inhibition to combat muscle wasting. iii iv Dedication This work was made possible due to many people: To my parents, John and Judy McCoy. They have always pushed and supported me in every aspect of my life. Without them behind me I would not be where I am today. I cannot thank them enough for their love and compassion in every aspect of my life. I owe them more than I could ever repay. To my sister Jennifer. Although at times we have not seen eye to eye we both know that no matter what we will be there for each other. I could not ask for a better role model and sister to look up to. To the many friends I have made along the way. Graduate school is both mentally and emotionally challenging. I have made too many friends to list them all here. They kept me sane and lifted me up when I was down. Thank you all. A special thanks to Erich Goebel and his wife Jessica Goebel. I was the best man at their wedding, and they will be the best man/maid of honor in mine. I have known them since day 1 of graduate school or longer and I could not ask for a better couple to spend these years and the future with. To my fiancée, Victoria Jensen. Anyone who knows me knows that I sometimes float a little too much, Victoria is my rock. She keeps me grounded, focused, and gives me the motivation to keep moving forward. Without her support this journey would have been infinitely harder. I cannot wait for our future together and to overcome every challenge in our way. v Acknowledgements First and foremost, I would like to thank my mentor, Tom Thompson, for giving me an amazing opportunity within his laboratory. Having known many of his previous and now current graduate students one thing remains consistent, Tom will push you. Not over an edge, but to greater heights. He motivates his students to not only be better scientist, but writers through involvement in grants, communicators through lab meetings and conferences, and overall, more well-rounded members of the scientific community. Without his guidance and constant support, I would not be writing this today. What is more, while pushing me to be a better scientist, he gave me room. Room to grow, make mistakes, and learn from those many, many mistakes. He provided the tools, the guidance, and the motivation to be better and for that I cannot thank him enough. I would also like to thank my committee members: Sean Davidson, Jeff Molkentin, and David Wieczorek for their valuable insight, feedback, constructive criticism, and overall support during my academic pursuits. Two other professors deserve recognition alone: Rhett Kovall and Bill Miller. While Tom was my primary mentor Rhett and Bill always supported me. Offering any expertise, reagents, or advice at any time. I cannot thank them enough for being another source of excellent mentorship during this journey. The Thompson Lab is full of great scientists, friends, and peers: Erich Goebel, Greg Gipson, Kaitlin Hart, Emily Kappes, Chandra Kattamuri, and Magda Czepnik. Every member of the current lab and two past members, Ryan Walker and Kristoff Nolan, have been integral to my success. Whether it is the exchange of ideas or the release of stress I owe them all a debt of gratitude. I would like to give a special thanks to Magda, her and I have worked very closely on many experiments and projects. Her dedication and work ethic are unparalleled. I cannot thank her enough for helping me finish a multitude of experiments and projects. vi Lastly, I would like to thank my soon-to-be wife Victoria. More than anyone else she has pushed me to where I am. We both went through graduate school together, supporting one another and succeeding together. Her strength is unrivaled, and I cannot wait for our future together. vii Table of Contents Abstract……………………………………………………………………………………………………………………………………………………ii Dedication…………………………………………………………………………………………………………………..………………………….iii Acknowledgements. …………………………………………………………………………………………………………………….………….v Table of Contents. ………………………………………………………………………………………………………………………………..viii List of Figures and Tables. ……………………………………………………………………………………………………………………...xi Chapter I: Introduction………………………………………………………………………………………………………………………..1 Introduction………………………………………………………………………………………………………………………………..2 Ligand domain architecture and signaling…………………………………………………………………………………...3 TGFβ superfamily ligand prodomains facilitate proper complex formation and regulation………….6 Structure of the TGFβ1 procomplex and mechanisms of activation……………………………………………..7 GDF8/11 procomplexes and mechanisms of activation……………………………………………………………...10 Extracellular antagonism of the TGFβ superfamily……………………………………………………………………..11 Aims of this dissertation..14 Chapter II: Molecular characterization of latent GDF8……………………………………………………………………… 16 Abstract…………………………………………………………………………………………………………………………………… 17 Significance……………………………………………………………………………………………………………………………… 17 Introduction…………………………………………………………………………………………………………………………….. 18 Results…………………………………………………………………………………………………………………………………….. 19 -Prodomain-GDF8 can exist in a latent and active complex…………………………………………. 19 -SAXS analysis reveals conformational differences between GDF8 and other TGFβ prodomain-ligand complexes…………………………………………………………………………………….… 22 -Specific mutation within the prodomain enhance GDF8 activity………………………………… 25 -GDF8 prodomain mutations exhibit reduced antagonism………………………………………….. 31 -Reformed complexes using the GDF8 prodomain mutants are more active and exhibit decreased thermal stability…………………………………………………………………………………………. 32 -GDF8 mutants enhance muscle atrophy compared with WT GDF8……………………………. 34 Discussion……………………………………………………………………………………………………………………………….. 36 Materials and methods…………………………………………………………………………………………………..………. 42 Acknowledgements………………………………………………………………………………………………………………… 49 viii Chapter III: Residues adjacent to the tolloid cut site of GDF8 and important for Tolloid mediated Activation………………………………………………………………………………………………………………………………………… 50 Abstract……………………………………………………………………………………………………………………………………
Recommended publications
  • A University of Sussex Phd Thesis Available Online Via
    A University of Sussex PhD thesis Available online via Sussex Research Online: http://sro.sussex.ac.uk/ This thesis is protected by copyright which belongs to the author. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Please visit Sussex Research Online for more information and further details Exploring interactions between Epstein- Barr virus transcription factor Zta and The Human Genome By IJIEL BARAK NARANJO PEREZ FERNANDEZ A Thesis submitted for the degree of Doctor of Philosophy University Of Sussex School of Life Sciences September 2017 ii I hereby declare that this thesis has not been and will not be, submitted in whole or in part to another University for the award of any other degree. Signature:…………………………..…………………………..……………………… iii Acknowledgements I want to thank Professor Alison J Sinclair for her guidance, mentoring and above all continuous patience. During the time that I’ve been part of her lab I’ve appreciated her wisdom as an educator her foresight as a scientist and tremendous love as a parent. I wish that someday soon rather than later her teachings are reflected in my person and career; hopefully inspiring others like me. Thanks to Professor Michelle West for her help whenever needed or offered. Her sincere and honest feedback, something that I only learned to appreciate after my personal scientific insight was developed.
    [Show full text]
  • Mechanical Forces Induce an Asthma Gene Signature in Healthy Airway Epithelial Cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T
    www.nature.com/scientificreports OPEN Mechanical forces induce an asthma gene signature in healthy airway epithelial cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T. Kho4, Kelan Tantisira1, Marc Santolini 1,5, Feixiong Cheng6,7,8, Jennifer A. Mitchel3, Maureen McGill3, Michael J. O’Sullivan3, Margherita De Marzio1,3, Amitabh Sharma1, Scott H. Randell9, Jefrey M. Drazen3, Jefrey J. Fredberg3 & Scott T. Weiss1,3* Bronchospasm compresses the bronchial epithelium, and this compressive stress has been implicated in asthma pathogenesis. However, the molecular mechanisms by which this compressive stress alters pathways relevant to disease are not well understood. Using air-liquid interface cultures of primary human bronchial epithelial cells derived from non-asthmatic donors and asthmatic donors, we applied a compressive stress and then used a network approach to map resulting changes in the molecular interactome. In cells from non-asthmatic donors, compression by itself was sufcient to induce infammatory, late repair, and fbrotic pathways. Remarkably, this molecular profle of non-asthmatic cells after compression recapitulated the profle of asthmatic cells before compression. Together, these results show that even in the absence of any infammatory stimulus, mechanical compression alone is sufcient to induce an asthma-like molecular signature. Bronchial epithelial cells (BECs) form a physical barrier that protects pulmonary airways from inhaled irritants and invading pathogens1,2. Moreover, environmental stimuli such as allergens, pollutants and viruses can induce constriction of the airways3 and thereby expose the bronchial epithelium to compressive mechanical stress. In BECs, this compressive stress induces structural, biophysical, as well as molecular changes4,5, that interact with nearby mesenchyme6 to cause epithelial layer unjamming1, shedding of soluble factors, production of matrix proteins, and activation matrix modifying enzymes, which then act to coordinate infammatory and remodeling processes4,7–10.
    [Show full text]
  • Two Locus Inheritance of Non-Syndromic Midline Craniosynostosis Via Rare SMAD6 and 4 Common BMP2 Alleles 5 6 Andrew T
    1 2 3 Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and 4 common BMP2 alleles 5 6 Andrew T. Timberlake1-3, Jungmin Choi1,2, Samir Zaidi1,2, Qiongshi Lu4, Carol Nelson- 7 Williams1,2, Eric D. Brooks3, Kaya Bilguvar1,5, Irina Tikhonova5, Shrikant Mane1,5, Jenny F. 8 Yang3, Rajendra Sawh-Martinez3, Sarah Persing3, Elizabeth G. Zellner3, Erin Loring1,2,5, Carolyn 9 Chuang3, Amy Galm6, Peter W. Hashim3, Derek M. Steinbacher3, Michael L. DiLuna7, Charles 10 C. Duncan7, Kevin A. Pelphrey8, Hongyu Zhao4, John A. Persing3, Richard P. Lifton1,2,5,9 11 12 1Department of Genetics, Yale University School of Medicine, New Haven, CT, USA 13 2Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA 14 3Section of Plastic and Reconstructive Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA 15 4Department of Biostatistics, Yale University School of Medicine, New Haven, CT, USA 16 5Yale Center for Genome Analysis, New Haven, CT, USA 17 6Craniosynostosis and Positional Plagiocephaly Support, New York, NY, USA 18 7Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA 19 8Child Study Center, Yale University School of Medicine, New Haven, CT, USA 20 9The Rockefeller University, New York, NY, USA 21 22 ABSTRACT 23 Premature fusion of the cranial sutures (craniosynostosis), affecting 1 in 2,000 24 newborns, is treated surgically in infancy to prevent adverse neurologic outcomes. To 25 identify mutations contributing to common non-syndromic midline (sagittal and metopic) 26 craniosynostosis, we performed exome sequencing of 132 parent-offspring trios and 59 27 additional probands.
    [Show full text]
  • Molecular Characterization of Latent GDF8 Reveals Mechanisms
    Molecular characterization of latent GDF8 reveals PNAS PLUS mechanisms of activation Ryan G. Walkera,1, Jason C. McCoya,1, Magdalena Czepnika, Melanie J. Millsb,c, Adam Haggd,e, Kelly L. Waltond, Thomas R. Cottonf, Marko Hyvönenf, Richard T. Leeb,c, Paul Gregorevice,g,h,i, Craig A. Harrisond,j,2, and Thomas B. Thompsona,2 aDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267; bHarvard Stem Cell Institute, Harvard University, Cambridge, MA 02138; cDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138; dBiomedicine Discovery Institute, Department of Physiology, Monash University, Clayton, VIC 3800, Australia; eBaker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; fDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom; gDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; hDepartment of Physiology, University of Melbourne, Parkville, VIC 3010, Australia; iDepartment of Neurology, University of Washington School of Medicine, Seattle, WA 98195; and jHudson Institute of Medical Research, Clayton, VIC 3168, Australia Edited by Se-Jin Lee, Johns Hopkins University, Baltimore, MD, and approved December 7, 2017 (received for review August 22, 2017) Growth/differentiation factor 8 (GDF8), or myostatin, negatively the latent TGF-β1 crystal structure provided a molecular expla- regulates muscle mass. GDF8 is held in a latent state through nation for how latency is exerted by the prodomain via a co- interactions with its N-terminal prodomain, much like TGF-β. Using ordinated interaction between the N-terminal alpha helix (alpha- a combination of small-angle X-ray scattering and mutagenesis, 1), latency lasso, and fastener of the prodomain with type I and we characterized the interactions of GDF8 with its prodomain.
    [Show full text]
  • Mutations in Mammalian Tolloid-Like 1 Gene Detected in Adult Patients with ASD
    European Journal of Human Genetics (2009) 17, 344 – 351 & 2009 Macmillan Publishers Limited All rights reserved 1018-4813/09 $32.00 www.nature.com/ejhg ARTICLE Mutations in mammalian tolloid-like 1 gene detected in adult patients with ASD Paweł Stan´ czak1, Joanna Witecka2, Anna Szydło2, Ewa Gutmajster2, Małgorzata Lisik2, Aleksandra Augus´ciak-Duma2, Maciej Tarnowski2, Tomasz Czekaj2, Hanna Czekaj2 and Aleksander L Sieron´ *,2 1Swietokrzyskie Center for Cardiology, Regional Hospital, Kielce, Poland; 2Department of General and Molecular Biology and Genetics, CoE for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, CoE Network, BioMedTech ‘Silesia’, Medical University of Silesia, Katowice, Poland Atrial septal defect (ASD) is an incomplete septation of atria in human heart causing circulatory problems. Its frequency is estimated at one per 10 000. Actions of numerous genes have been linked to heart development. However, no single gene defect causing ASD has yet been identified. Incomplete heart septation similar to ASD was reported in transgenic mice with both inactive alleles of gene encoding mammalian zinc metalloprotease a mammalian tolloid-like 1 (tll1). Here, we have screened 19 ASD patients and 15 healthy age-matched individuals for mutations in TLL1 gene. All 22 exons were analyzed exon by exon for heteroduplex formation. Subsequently, DNA fragments forming heteroduplexes were sequenced. In four nonrelated patients, three missense mutations in coding sequence, and one single base change in the 50UTR have been detected. Two mutations (Met182Leu, and Ala238Val) were detected in ASD patients with the same clinical phenotype. As the second mutation locates immediately upstream of the catalytic zinc-binding signature, it might change the enzyme substrate specificity.
    [Show full text]
  • Revealing the Role of the Human Blood Plasma Proteome in Obesity Using Genetic Drivers
    ARTICLE https://doi.org/10.1038/s41467-021-21542-4 OPEN Revealing the role of the human blood plasma proteome in obesity using genetic drivers Shaza B. Zaghlool 1,11, Sapna Sharma2,3,4,11, Megan Molnar 2,3, Pamela R. Matías-García2,3,5, Mohamed A. Elhadad 2,3,6, Melanie Waldenberger 2,3,7, Annette Peters 3,4,7, Wolfgang Rathmann4,8, ✉ Johannes Graumann 9,10, Christian Gieger2,3,4, Harald Grallert2,3,4,12 & Karsten Suhre 1,12 Blood circulating proteins are confounded readouts of the biological processes that occur in 1234567890():,; different tissues and organs. Many proteins have been linked to complex disorders and are also under substantial genetic control. Here, we investigate the associations between over 1000 blood circulating proteins and body mass index (BMI) in three studies including over 4600 participants. We show that BMI is associated with widespread changes in the plasma proteome. We observe 152 replicated protein associations with BMI. 24 proteins also associate with a genome-wide polygenic score (GPS) for BMI. These proteins are involved in lipid metabolism and inflammatory pathways impacting clinically relevant pathways of adiposity. Mendelian randomization suggests a bi-directional causal relationship of BMI with LEPR/LEP, IGFBP1, and WFIKKN2, a protein-to-BMI relationship for AGER, DPT, and CTSA, and a BMI-to-protein relationship for another 21 proteins. Combined with animal model and tissue-specific gene expression data, our findings suggest potential therapeutic targets fur- ther elucidating the role of these proteins in obesity associated pathologies. 1 Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Doha, Qatar.
    [Show full text]
  • Supplemental Table 1. Complete Gene Lists and GO Terms from Figure 3C
    Supplemental Table 1. Complete gene lists and GO terms from Figure 3C. Path 1 Genes: RP11-34P13.15, RP4-758J18.10, VWA1, CHD5, AZIN2, FOXO6, RP11-403I13.8, ARHGAP30, RGS4, LRRN2, RASSF5, SERTAD4, GJC2, RHOU, REEP1, FOXI3, SH3RF3, COL4A4, ZDHHC23, FGFR3, PPP2R2C, CTD-2031P19.4, RNF182, GRM4, PRR15, DGKI, CHMP4C, CALB1, SPAG1, KLF4, ENG, RET, GDF10, ADAMTS14, SPOCK2, MBL1P, ADAM8, LRP4-AS1, CARNS1, DGAT2, CRYAB, AP000783.1, OPCML, PLEKHG6, GDF3, EMP1, RASSF9, FAM101A, STON2, GREM1, ACTC1, CORO2B, FURIN, WFIKKN1, BAIAP3, TMC5, HS3ST4, ZFHX3, NLRP1, RASD1, CACNG4, EMILIN2, L3MBTL4, KLHL14, HMSD, RP11-849I19.1, SALL3, GADD45B, KANK3, CTC- 526N19.1, ZNF888, MMP9, BMP7, PIK3IP1, MCHR1, SYTL5, CAMK2N1, PINK1, ID3, PTPRU, MANEAL, MCOLN3, LRRC8C, NTNG1, KCNC4, RP11, 430C7.5, C1orf95, ID2-AS1, ID2, GDF7, KCNG3, RGPD8, PSD4, CCDC74B, BMPR2, KAT2B, LINC00693, ZNF654, FILIP1L, SH3TC1, CPEB2, NPFFR2, TRPC3, RP11-752L20.3, FAM198B, TLL1, CDH9, PDZD2, CHSY3, GALNT10, FOXQ1, ATXN1, ID4, COL11A2, CNR1, GTF2IP4, FZD1, PAX5, RP11-35N6.1, UNC5B, NKX1-2, FAM196A, EBF3, PRRG4, LRP4, SYT7, PLBD1, GRASP, ALX1, HIP1R, LPAR6, SLITRK6, C16orf89, RP11-491F9.1, MMP2, B3GNT9, NXPH3, TNRC6C-AS1, LDLRAD4, NOL4, SMAD7, HCN2, PDE4A, KANK2, SAMD1, EXOC3L2, IL11, EMILIN3, KCNB1, DOK5, EEF1A2, A4GALT, ADGRG2, ELF4, ABCD1 Term Count % PValue Genes regulation of pathway-restricted GDF3, SMAD7, GDF7, BMPR2, GDF10, GREM1, BMP7, LDLRAD4, SMAD protein phosphorylation 9 6.34 1.31E-08 ENG pathway-restricted SMAD protein GDF3, SMAD7, GDF7, BMPR2, GDF10, GREM1, BMP7, LDLRAD4, phosphorylation
    [Show full text]
  • Genomic Analysis of a Spinal Muscular Atrophy
    Jiang et al. BMC Medical Genetics (2019) 20:204 https://doi.org/10.1186/s12881-019-0935-3 CASE REPORT Open Access Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report Jianping Jiang1,2†, Jinwei Huang3†, Jianlei Gu1,2,4, Xiaoshu Cai4, Hongyu Zhao1,2* and Hui Lu1,4* Abstract Background: Spinal muscular atrophy (SMA) is a rare neuromuscular disorder threating hundreds of thousands of lives worldwide. And the severity of SMA differs among different clinical types, which has been demonstrated to be modified by factors like SMN2, SERF1, NAIP, GTF2H2 and PLS3. However, the severities of many SMA cases, especially the cases within a family, often failed to be explained by these modifiers. Therefore, other modifiers are still waiting to be explored. Case presentation: In this study, we presented a rare case of SMA discordant family with a mild SMA male patient and a severe SMA female patient. The two SMA cases fulfilled the diagnostic criteria defined by the International SMA Consortium. With whole exome sequencing, we confirmed the heterozygous deletion of exon7 at SMN1 on the parents’ genomes and the homozygous deletions on the two patients’ genomes. The MLPA results confirmed the deletions and indicated that all the family members carry two copies of SMN2, SERF1, NAIP and GTF2H2. Further genomic analysis identified compound heterozygous mutations at TLL2 on the male patient’s genome, and compound heterozygous mutations at VPS13A and the de novo mutation at AGAP5 on female patient’s genome.
    [Show full text]
  • Transcriptomic Profiles of High and Low Antibody Responders to Smallpox
    Genes and Immunity (2013) 14, 277–285 & 2013 Macmillan Publishers Limited All rights reserved 1466-4879/13 www.nature.com/gene ORIGINAL ARTICLE Transcriptomic profiles of high and low antibody responders to smallpox vaccine RB Kennedy1,2, AL Oberg1,3, IG Ovsyannikova1,2, IH Haralambieva1,2, D Grill1,3 and GA Poland1,2 Despite its eradication over 30 years ago, smallpox (as well as other orthopox viruses) remains a pathogen of interest both in terms of biodefense and for its use as a vector for vaccines and immunotherapies. Here we describe the application of mRNA-Seq transcriptome profiling to understanding immune responses in smallpox vaccine recipients. Contrary to other studies examining gene expression in virally infected cell lines, we utilized a mixed population of peripheral blood mononuclear cells in order to capture the essential intercellular interactions that occur in vivo, and would otherwise be lost, using single cell lines or isolated primary cell subsets. In this mixed cell population we were able to detect expression of all annotated vaccinia genes. On the host side, a number of genes encoding cytokines, chemokines, complement factors and intracellular signaling molecules were downregulated upon viral infection, whereas genes encoding histone proteins and the interferon response were upregulated. We also identified a small number of genes that exhibited significantly different expression profiles in subjects with robust humoral immunity compared with those with weaker humoral responses. Our results provide evidence that differential gene regulation patterns may be at work in individuals with robust humoral immunity compared with those with weaker humoral immune responses. Genes and Immunity (2013) 14, 277–285; doi:10.1038/gene.2013.14; published online 18 April 2013 Keywords: Next-generation sequencing; mRNA-Seq; vaccinia virus; smallpox vaccine INTRODUCTION these 44 subjects had two samples (uninfected and vaccinia Vaccinia virus (VACV) is the immunologically cross-protective infected).
    [Show full text]
  • Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes
    Diabetes Volume 69, August 2020 1843 Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes Valborg Gudmundsdottir,1,2 Shaza B. Zaghlool,3 Valur Emilsson,2,4 Thor Aspelund,1,2 Marjan Ilkov,2 Elias F. Gudmundsson,2 Stefan M. Jonsson,1 Nuno R. Zilhão,2 John R. Lamb,5 Karsten Suhre,3 Lori L. Jennings,6 and Vilmundur Gudnason1,2 Diabetes 2020;69:1843–1853 | https://doi.org/10.2337/db19-1070 GENETICS/GENOMES/PROTEOMICS/METABOLOMICS The increasing prevalence of type 2 diabetes poses More than 240 genetic loci have been associated with type a major challenge to societies worldwide. Blood-based 2 diabetes in genome-wide association studies (GWAS) factors like serum proteins are in contact with every (1–5), and blood-based biomarker candidates for type organ in the body to mediate global homeostasis and 2 diabetes have begun to emerge, perhaps most notably may thus directly regulate complex processes such as the branched-chain amino acids (BCAAs) (6,7), the catab- aging and the development of common chronic dis- olism of which has recently been proposed as a novel eases. We applied a data-driven proteomics approach, treatment target for obesity-associated insulin resistance measuring serum levels of 4,137 proteins in 5,438 elderly (8). However, only fragmentary data are available for Icelanders, and identified 536 proteins associated with serum protein links to type 2 diabetes (9). While few prevalent and/or incident type 2 diabetes. We validated biomarker candidates provide much improvement in a subset of the observed associations in an independent type 2 diabetes prediction over conventional measures case-control study of type 2 diabetes.
    [Show full text]
  • Influence of WFIKKN1 on BMP1‐Mediated
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Repository of the Academy's Library Influence of WFIKKN1 on BMP1-mediated activation of latent myostatin Gyorgy€ Szlama, Viktor Vas arhelyi, Maria Trexler and Laszl o Patthy Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary Keywords The NTR domain of WFIKKN1 protein has been shown to have signifi- BMP1; heparin; latent myostatin; myostatin; cant affinity for the prodomain regions of promyostatin and latent myo- WFIKKN1 statin but the biological significance of these interactions remained unclear. In view of its role as a myostatin antagonist, we tested the assumption that Correspondence L. Patthy, Institute of Enzymology, WFIKKN1 inhibits the release of myostatin from promyostatin and/or Research Centre for Natural Sciences, latent myostatin. WFIKKN1 was found to have no effect on processing of Hungarian Academy of Sciences, Budapest, promyostatin by furin, the rate of cleavage of latent myostatin by BMP1, P.O. Box 286, H-1519, Hungary however, was significantly enhanced in the presence of WFIKKN1 and Tel: +361 382 6751 this enhancer activity was superstimulated by heparin. Unexpectedly, E-mail: [email protected] WFIKKN1 was also cleaved by BMP1 and our studies have shown that the KKN1 fragment generated by BMP1-cleavage of WFIKKN1 con- (Received 26 May 2016, revised 19 September 2016, accepted 24 October tributes most significantly to the observed enhancer activity. Analysis of a 2016) pro-TGF-b -based homology model of homodimeric latent myostatin revealed that the BMP1-cleavage sites are buried and not readily accessible doi:10.1111/febs.13938 to BMP1.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]